F. Gamarra (Straubing, Germany), W. van Geffen (Leeuwarden, Netherlands)
This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
A basic prediction model with clinical parameters to diagnose lung cancer.
M. van Engeland (Enschede, Netherlands), S. Kort (Enschede, Netherlands), J. Van Der Palen (Enschede, Netherlands)
|   |
Proportion of incident lung cancers that would have been eligible for a lung cancer screening program in Australia
M. Turner (Canberra, Australia), L. Smyth (Canberra, Australia), N. Taylor (Canberra, Australia), S. Schembri (Canberra, Australia)
| |
DR-70, A promising biomarker for the detection of lung cancer>
G. Özgül (Istanbul, Turkey), A. Koç (Agri, Turkey), D. Turan (Istanbul, Turkey), S. Küçük (Istanbul, Turkey), S. Özsoy (Istanbul, Turkey), K. Baydili (Istanbul, Turkey), E. Güler (Istanbul, Turkey), M. Özgül (Istanbul, Turkey), Z. Egri Kansu (Istanbul, Turkey), E. Seyhan (Istanbul, Turkey)
| |
Impact of a lung cancer screening programme on a London hospital service
E. Thompson (London, United Kingdom), W. Ricketts (London, United Kingdom), S. Uys (London, United Kingdom), L. Castle (London, United Kingdom)
| |
Lung nodules: a diagnosis’ challenge in Pulmonology
M. Ramos Martins (Porto, Portugal), C. Freitas (Porto, Portugal), D. Coelho (Porto, Portugal), C. Sousa (Porto, Portugal), V. Santos (Porto, Portugal), J. Pereira (Porto, Portugal), C. Souto-Moura (Porto, Portugal), V. Hespanhol (Porto, Portugal)
| |
Non-small-cell lung cancer molecular typification using Next-generation sequencing in cytological samples from EBUS-TBNA
B. Urrutia Royo (Barcelona, Spain), C. Centeno Clemente (Barcelona, Spain), J. Mate Sanz (Barcelona, Spain), E. Carcereny Costa (Barcelona, Spain), P. Serra Mitja (Barcelona, Spain), M. Ávila Terzi (Barcelona, Spain), R. Tazi Mezalek (Barcelona, Spain), A. Rosell Gratacos (Barcelona, Spain), F. Andreo Garcia (Barcelona, Spain)
| |
Iodine-125 seed brachytherapy combined with pembrolizumab for advanced non-small-cell lung cancer after failure of first-line chemotherapy.
M. Yuan (Wuhan, China), Y. Hu (Wuhan, China), L. Wang (Wuhan, China), Y. Xiao (Wuhan, China), X. Guo (Wuhan, China)
| |
Alpha-1 antitrypsin deficiency and lung cancer: Description of a cohort of patients in northwestern Spain
R. Tubio Perez (Vigo, Pontevedra, Spain), M. Torres Durán (Vigo, Pontevedra, Spain), E. Garcia Rodriguez (Vigo, Pontevedra, Spain), R. Dacal Quintas (Ourense, Spain), J. Abal Arca (Ourense, Spain), I. Parente Lamelas (Ourense, Spain), C. Vilariño Pombo (Vigo, Pontevedra, Spain), A. Ruano Raviña (Santiago de Compostela, Spain), A. Fernandez Villar (Santiago de Compostela, Spain)
| |
LUNG ADENOCARCINOMA: CLINICAL CHARACTERISTICS, MOLECULAR STUDY, DIAGNOSIS AND TREATMENT.
F. Garcia (Getafe, Spain), M. Rio Ramirez (Getafe, Spain), A. Sanchez Peña (Getafe, Spain), J. Diaz Garcia (Getafe, Spain), B. Raboso Moreno (Getafe, Spain), A. Rodriguez Perojo (Getafe, Spain), A. Abad Fernandez (Getafe, Spain)
| |
Epithelioid hemangioendothelioma of the lungs: 24 cases
T. Novitskaya (St. Petersburg, Russian Federation), I. Dvorakovskaya (St. Petersburg, Russian Federation), B. Ariel (St. Petersburg, Russian Federation), L. Novikova (St. Petersburg, Russian Federation), S. Bugrov (St. Petersburg, Russian Federation)
| |
Radial endobronchial ultrasound guided transbronchial cryobiopsy with fluoroscopy in the diagnosis of peripheral lung tumor: experience of the Hospital of Lithuanian University of Health Sciences Kauno Klinikos
V. Ankudavicius (Kaunas, Lithuania), M. Zemaitis (Kaunas, Lithuania), S. Miliauskas (Kaunas, Lithuania)
| |
First hospitalization in lung cancer patients – is timing important?
M. Conde (Vila Real, Portugal), S. Raimundo (Vila Real, Portugal), M. Brandão (Porto, Portugal), C. Parra (Vila Real, Portugal), A. Vale (Vila Real, Portugal), A. Fernandes (Vila Real, Portugal)
| |
Impact of PD-L1 expression levels on the response to pembrolizumab in metastatic non-small cell lung cancer>
J. Nunes Caldeira Marinho Matos (Coimbra, Portugal), S. Rodrigues Sousa (Coimbra, Portugal), A. Figueiredo (Coimbra, Portugal), A. Pego (Coimbra, Portugal), F. Barata (Coimbra, Portugal)
| |
The importance of the disease-free survival (DFS) endpoint to survivors of lung cancer
A. Bever (Vancouver, Canada), J. Manthorne (Ottawa, Canada), T. Rahim (Vancouver, Canada), L. Moumin (Ottawa, Canada), K. Johnston (Vancouver, Canada), S. Szabo (Vancouver, Canada)
| |
Respiratory symptoms in lung cancer survivors after one-year radiotherapy treatment
A. Heredia Ciuró (Granada, Spain), J. Villen-Villen (Granada, Spain), A. Lazo-Prados (Granada, Spain), J. Remedios-Torres (Granada, Spain), E. Prados-Roman (Granada, Spain), M. Valenza (Granada, Spain)
| |